PARP inhibition protects mitochondria and reduces ROS production

Flavonoids from Rosa roxburghii Tratt prevent reactive oxygen

BGP-15 Protects against Oxidative Stress- or Lipopolysaccharide

Mitochondrial dysfunction in fibrotic diseases

Frontiers PARP Inhibitor PJ34 Protects Mitochondria and Induces DNA-Damage Mediated Apoptosis in Combination With Cisplatin or Temozolomide in B16F10 Melanoma Cells

Propofol inhibits parthanatos via ROS–ER–calcium–mitochondria

ROS‐Mediated PARP Activity Undermines Mitochondrial Function After

Interplay between ADP-ribosyltransferases and essential cell signaling pathways controls cellular responses

Construction and validation of a novel NAD+ metabolism‐related risk model for prognostic prediction in osteosarcoma - Yu - Journal of Orthopaedic Research - Wiley Online Library

IJMS, Free Full-Text

Early loss of endogenous NAD+ following rotenone treatment leads to Sarm1 activation that is ameliorated by PARP inhibition

Elesclomol, a copper-transporting therapeutic agent targeting